Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD19 binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neuromyelitis Optica 4 D009471 ClinicalTrials
Immunoglobulin G4-Related Disease 3 D000077733 ClinicalTrials
Myasthenia Gravis 3 D009157 ClinicalTrials
Encephalitis, Japanese 2 D004672 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Multiple Sclerosis 1 D009103 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Scleroderma, Localized 1 D012594 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109334
FDA SRS 74T7185BMM